Guardant Health (MEX:GH) Net Margin %: -37.15% (As of Mar. 2026)


MEX:GH Guardant Health Inc MEX:GH
67 GF Score
Price MXN2,080.00
GF Value MXN879.06
! 4 Warning Signs
View Full Analysis

What is Guardant Health Net Margin %?

Guardant Health MEX:GH 67 Net Margin % is -37.15% as of Mar. 2026. GuruFocus rates MEX:GH with a GF Score™ of 67/100 and a GF Value™ of MXN879.06. The stock has 4 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Guardant Health ranks worse than 74.02% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Guardant Health's Net Income for the three months ended in Mar. 2026 was MXN-2,021 Mil. Guardant Health's Revenue for the three months ended in Mar. 2026 was MXN5,440 Mil. Therefore, Guardant Health's net margin for the quarter that ended in Mar. 2026 was -37.15%.

The historical rank and industry rank for Guardant Health's Net Margin % or its related term are showing as below:

MEX:GH' s Net Margin % Range Over the Past 10 Years
Min: -182.74   Med: -91.18   Max: -35.29
Current: -40.1

MEX:GH's Net Margin % is ranked worse than
74.02% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: -2.405 vs MEX:GH: -40.10

Guardant Health  (MEX:GH) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Guardant Health Net Margin % Related Terms

Guardant Health Net Margin % Historical Data

* Premium members only.

The historical data trend for Guardant Health's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guardant Health Net Margin % Chart

Guardant Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -108.57 -145.61 -85.02 -59.05 -42.39

Guardant Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -46.77 -43.04 -34.96 -45.68 -37.15

MEX:GH vs LH, DGX, MEDP: Net Margin % Comparison

For the Diagnostics & Research subindustry, Guardant Health's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guardant Health Net Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Guardant Health's Net Margin % distribution charts can be found below:

* The bar in red indicates where Guardant Health's Net Margin % falls into.


MEX:GH
67GF Score
Guardant Health Inc MEX:GH
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guardant Health Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Guardant Health's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-7495.359/17681.976
=-42.39 %

Guardant Health's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-2021.015/5439.834
=-37.15 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -37.15% mean?
Guardant Health (MEX:GH) has a Net Margin % of -37.15% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Guardant Health and its competitors. According to the industry distribution chart, Guardant Health ranks #151 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 74%.
Is Guardant Health's Net Margin % too high?
Guardant Health's current Net Margin % is -37.15%. Based on the distribution chart, Guardant Health ranks #151 out of 204 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Guardant Health has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Guardant Health's Net Margin % compare to LH and DGX?
According to the Medical Diagnostics & Research industry distribution chart, Guardant Health ranks #151 out of 204 companies for Net Margin %. This places Guardant Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Diagnostics & Research company?
A good Net Margin % depends on the Medical Diagnostics & Research industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Guardant Health and its competitors. Guardant Health's current Net Margin % is -37.15%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guardant Health stock overvalued right now?
Guardant Health (MEX:GH) has a current Net Margin % of -37.15%. The stock's GF Value™ is MXN879.06, compared to a current price of MXN2,080.00 — trading 136.6% above its estimated fair value. The current Net Margin % is -37.15%. Guardant Health's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Guardant Health (MEX:GH), the current Net Margin % is -37.15% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guardant Health (MEX:GH) Overvalued in 2026?

Based on GuruFocus' analysis, Guardant Health stock appears to be overvalued. The current stock price of MXN2,080.00 is trading 136.6% above its estimated GF Value™ of MXN879.06.

Key valuation signals for MEX:GH:

  • Net Margin %: -37.15%
  • GF Value™: MXN879.06 vs. price of MXN2,080.00 (136.6% above fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the MEX:GH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guardant Health Business Description

Other Exchanges GH:USA1GH:Italy5GH:Germany
Address 3100 Hanover Street, Palo Alto, CA, USA, 94304
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
67GF Score

Get the complete analysis for MEX:GH

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN2,080.00
Price
MXN879.06
GF Value